Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
This rapidly growing field is continuously uncovering new therapeutic peptides designed to target specific diseases and conditions, offering hope for more personalized and effective treatments
For sample preparation, the labeled stock solution was further diluted to obtain working solutions with concentrations suitable for spiking purposes in the range of 0.01 and 0.5 g/mL
Use within 28 days, then reconstitute next vial
canettii and M
gastric ulcers, duodenal ulcers, and mucosal erosion where direct local peptide delivery to the damaged tissue is the therapeutic goal Inflammatory bowel conditions: Crohn's disease and ulcerative colitis support, where VEGF-mediated mucosal angiogenesis and anti-inflammatory effects have been investigated Leaky gut and intestinal hyperpermeability: tight junction restoration and mucosal integrity support in patients with compromised gut barrier function Gastroparesis: pro-motility effects via vagal cholinergic pathways investigated in preclinical models of delayed gastric emptying
US$ 29.96
US$ 22.44
US$ 27.48
